Tenon MedicalTNON -10.39%38 Days Payable is 156.74 as of Mar. 2026, which is 12% above its 10-year median of 140.27. GuruFocus rates TNON with a GF Score™ of 38/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Tenon Medical ranks better than 78.99% on this metric.
The historical rank and industry rank for Tenon Medical's Days Payable or its related term are showing as below:
TNON'
s Days Payable Range Over the Past 10 Years
Min: 93.46 Med: 140.27 Max: 11943.61
Current: 158.28
During the past 6 years, Tenon Medical's highest Days Payable was 11943.61. The lowest was 93.46. And the median was 140.27.
TNON's Days Payable is ranked better than 78.99% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs TNON: 158.28
Tenon Medical's Days Payable
increased
from Mar. 2025 (97.93) to Mar. 2026 (156.74).
It may suggest that Tenon Medicaldelayed paying its suppliers.
Tenon Medical Days Payable Related Terms
Tenon Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Tenon Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tenon Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenon Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Tenon Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Tenon Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenon Medical (TNON) has a Days Payable of 156.74 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tenon Medical and its competitors. This is 12% above median its historical median of 140.27. Over the past decade, Tenon Medical's Days Payable has ranged from 93.46 to 11,943.61. According to the industry distribution chart, Tenon Medical ranks #167 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Tenon Medical's Days Payable too high?
Tenon Medical's current Days Payable of 156.74 is 12% above median its 10-year median of 140.27. Over the past 10 years, this metric has ranged from a low of 93.46 to a high of 11,943.61. The Medical Devices & Instruments industry median Days Payable is 68.07. Tenon Medical's value of 156.74 is 130.3% above this industry median. Based on the distribution chart, Tenon Medical ranks #167 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tenon Medical has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's Days Payable compare to XAIR and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Tenon Medical ranks #167 out of 795 companies for Days Payable. This places Tenon Medical in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Tenon Medical's value of 156.74 is 130.3% above this benchmark. Historically, Tenon Medical's own Days Payable has ranged from 93.46 to 11,943.61 over the past decade. While the company's 10-year median is 140.27 vs. the industry median of 68.07, Tenon Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tenon Medical's current Days Payable of 156.74 is 130.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Tenon Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenon Medical's current Days Payable is 156.74, which is 12% above median its own 10-year median of 140.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current Days Payable is 156.74, which is 12% above median its 10-year median of 140.27 and 130.3% above the Medical Devices & Instruments industry median of 68.07. Tenon Medical's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Tenon Medical (TNON), the current Days Payable is 156.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenon Medical (TNON) Overvalued in 2026?
Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued.
The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35.
GuruFocus considers Tenon Medical to be Modestly Undervalued.
Key valuation signals for TNON:
Days Payable: 156.74 (12% above median its 10-year median of 140.27)
GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
Industry Position: 130.3% above the Medical Devices & Instruments median (#167 of 795)
No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
38GF Score
Get the complete analysis for TNON
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TNON has been successfully added to your 
